nodes	percent_of_prediction	percent_of_DWPC	metapath
Saxagliptin—SLCO4C1—Methotrexate—colon cancer	0.289	0.34	CbGbCtD
Saxagliptin—ABCC1—Irinotecan—colon cancer	0.148	0.174	CbGbCtD
Saxagliptin—ABCC1—Vincristine—colon cancer	0.129	0.152	CbGbCtD
Saxagliptin—ABCC1—Methotrexate—colon cancer	0.0782	0.0923	CbGbCtD
Saxagliptin—SLC22A8—Methotrexate—colon cancer	0.0608	0.0718	CbGbCtD
Saxagliptin—CYP3A5—Irinotecan—colon cancer	0.0548	0.0647	CbGbCtD
Saxagliptin—CYP3A5—Vincristine—colon cancer	0.0479	0.0565	CbGbCtD
Saxagliptin—CYP3A4—Irinotecan—colon cancer	0.0214	0.0252	CbGbCtD
Saxagliptin—CYP3A4—Vincristine—colon cancer	0.0187	0.022	CbGbCtD
Saxagliptin—DPP8—smooth muscle tissue—colon cancer	0.00636	0.0804	CbGeAlD
Saxagliptin—DPP4—blood vessel—colon cancer	0.0057	0.072	CbGeAlD
Saxagliptin—Idiopathic thrombocytopenic purpura—Capecitabine—colon cancer	0.0056	0.0763	CcSEcCtD
Saxagliptin—DPP8—bone marrow—colon cancer	0.00463	0.0585	CbGeAlD
Saxagliptin—DPP8—vagina—colon cancer	0.00444	0.0561	CbGeAlD
Saxagliptin—Immunodeficiency—Methotrexate—colon cancer	0.00417	0.0568	CcSEcCtD
Saxagliptin—DPP9—liver—colon cancer	0.00411	0.052	CbGeAlD
Saxagliptin—SLCO4C1—renal system—colon cancer	0.00388	0.049	CbGeAlD
Saxagliptin—DPP8—liver—colon cancer	0.00374	0.0473	CbGeAlD
Saxagliptin—DPP4—embryo—colon cancer	0.0034	0.043	CbGeAlD
Saxagliptin—DPP9—lymph node—colon cancer	0.00315	0.0398	CbGeAlD
Saxagliptin—SLCO4C1—bone marrow—colon cancer	0.00293	0.037	CbGeAlD
Saxagliptin—DPP8—lymph node—colon cancer	0.00287	0.0363	CbGeAlD
Saxagliptin—Lymphopenia—Irinotecan—colon cancer	0.00284	0.0386	CcSEcCtD
Saxagliptin—SLCO4C1—vagina—colon cancer	0.00281	0.0355	CbGeAlD
Saxagliptin—DPP4—epithelium—colon cancer	0.00277	0.0351	CbGeAlD
Saxagliptin—DPP4—smooth muscle tissue—colon cancer	0.00267	0.0338	CbGeAlD
Saxagliptin—DPP4—renal system—colon cancer	0.00257	0.0325	CbGeAlD
Saxagliptin—SLCO4C1—liver—colon cancer	0.00237	0.0299	CbGeAlD
Saxagliptin—DPP4—lymphoid tissue—colon cancer	0.00214	0.027	CbGeAlD
Saxagliptin—DPP4—digestive system—colon cancer	0.00211	0.0267	CbGeAlD
Saxagliptin—DPP4—bone marrow—colon cancer	0.00195	0.0246	CbGeAlD
Saxagliptin—Lymphopenia—Capecitabine—colon cancer	0.0019	0.0259	CcSEcCtD
Saxagliptin—DPP4—vagina—colon cancer	0.00186	0.0236	CbGeAlD
Saxagliptin—Opportunistic infection—Methotrexate—colon cancer	0.0018	0.0245	CcSEcCtD
Saxagliptin—SLC22A8—renal system—colon cancer	0.00169	0.0214	CbGeAlD
Saxagliptin—Hypertriglyceridaemia—Capecitabine—colon cancer	0.00169	0.023	CcSEcCtD
Saxagliptin—DPP4—liver—colon cancer	0.00157	0.0199	CbGeAlD
Saxagliptin—Blood triglycerides increased—Capecitabine—colon cancer	0.00148	0.0202	CcSEcCtD
Saxagliptin—Fracture—Methotrexate—colon cancer	0.00124	0.017	CcSEcCtD
Saxagliptin—Multiple fractures—Methotrexate—colon cancer	0.00124	0.017	CcSEcCtD
Saxagliptin—DPP4—lymph node—colon cancer	0.00121	0.0152	CbGeAlD
Saxagliptin—CYP3A5—renal system—colon cancer	0.00112	0.0141	CbGeAlD
Saxagliptin—ABCC1—vagina—colon cancer	0.00105	0.0133	CbGeAlD
Saxagliptin—Blood creatinine increased—Irinotecan—colon cancer	0.000987	0.0134	CcSEcCtD
Saxagliptin—CYP3A5—digestive system—colon cancer	0.000917	0.0116	CbGeAlD
Saxagliptin—Nasopharyngitis—Fluorouracil—colon cancer	0.000903	0.0123	CcSEcCtD
Saxagliptin—Pancreatitis—Irinotecan—colon cancer	0.000893	0.0122	CcSEcCtD
Saxagliptin—ABCC1—liver—colon cancer	0.000889	0.0112	CbGeAlD
Saxagliptin—Erectile dysfunction—Vincristine—colon cancer	0.000861	0.0117	CcSEcCtD
Saxagliptin—Upper respiratory tract infection—Irinotecan—colon cancer	0.000847	0.0115	CcSEcCtD
Saxagliptin—CYP3A4—renal system—colon cancer	0.000839	0.0106	CbGeAlD
Saxagliptin—Upper respiratory tract infection—Fluorouracil—colon cancer	0.000811	0.011	CcSEcCtD
Saxagliptin—CYP3A5—vagina—colon cancer	0.00081	0.0102	CbGeAlD
Saxagliptin—Gastroenteritis—Capecitabine—colon cancer	0.000796	0.0108	CcSEcCtD
Saxagliptin—Infestation NOS—Fluorouracil—colon cancer	0.000778	0.0106	CcSEcCtD
Saxagliptin—Infestation—Fluorouracil—colon cancer	0.000778	0.0106	CcSEcCtD
Saxagliptin—Urinary tract infection—Fluorouracil—colon cancer	0.000756	0.0103	CcSEcCtD
Saxagliptin—Purpura—Capecitabine—colon cancer	0.000732	0.00997	CcSEcCtD
Saxagliptin—Sinusitis—Fluorouracil—colon cancer	0.00073	0.00994	CcSEcCtD
Saxagliptin—CYP3A4—digestive system—colon cancer	0.000688	0.0087	CbGeAlD
Saxagliptin—CYP3A5—liver—colon cancer	0.000683	0.00864	CbGeAlD
Saxagliptin—ABCC1—lymph node—colon cancer	0.000682	0.00862	CbGeAlD
Saxagliptin—Face oedema—Capecitabine—colon cancer	0.000681	0.00928	CcSEcCtD
Saxagliptin—Blood creatinine increased—Capecitabine—colon cancer	0.000661	0.009	CcSEcCtD
Saxagliptin—Immune system disorder—Irinotecan—colon cancer	0.000659	0.00897	CcSEcCtD
Saxagliptin—Nasopharyngitis—Capecitabine—colon cancer	0.000631	0.00859	CcSEcCtD
Saxagliptin—Flatulence—Irinotecan—colon cancer	0.000625	0.00852	CcSEcCtD
Saxagliptin—Gastritis—Capecitabine—colon cancer	0.000624	0.0085	CcSEcCtD
Saxagliptin—Upper respiratory tract infection—Capecitabine—colon cancer	0.000567	0.00772	CcSEcCtD
Saxagliptin—Myalgia—Vincristine—colon cancer	0.000555	0.00756	CcSEcCtD
Saxagliptin—Infestation NOS—Capecitabine—colon cancer	0.000544	0.0074	CcSEcCtD
Saxagliptin—Infestation—Capecitabine—colon cancer	0.000544	0.0074	CcSEcCtD
Saxagliptin—Anaphylactic shock—Vincristine—colon cancer	0.000532	0.00725	CcSEcCtD
Saxagliptin—Infection—Vincristine—colon cancer	0.000528	0.0072	CcSEcCtD
Saxagliptin—Urinary tract infection—Capecitabine—colon cancer	0.000528	0.0072	CcSEcCtD
Saxagliptin—Thrombocytopenia—Vincristine—colon cancer	0.000521	0.00709	CcSEcCtD
Saxagliptin—Anaphylactic shock—Irinotecan—colon cancer	0.000518	0.00706	CcSEcCtD
Saxagliptin—Myalgia—Fluorouracil—colon cancer	0.000518	0.00705	CcSEcCtD
Saxagliptin—Infection—Irinotecan—colon cancer	0.000515	0.00701	CcSEcCtD
Saxagliptin—CYP3A4—liver—colon cancer	0.000513	0.00648	CbGeAlD
Saxagliptin—Thrombocytopenia—Irinotecan—colon cancer	0.000507	0.00691	CcSEcCtD
Saxagliptin—Anaphylactic shock—Fluorouracil—colon cancer	0.000496	0.00676	CcSEcCtD
Saxagliptin—Infection—Fluorouracil—colon cancer	0.000493	0.00671	CcSEcCtD
Saxagliptin—Thrombocytopenia—Fluorouracil—colon cancer	0.000486	0.00662	CcSEcCtD
Saxagliptin—Musculoskeletal discomfort—Vincristine—colon cancer	0.000485	0.0066	CcSEcCtD
Saxagliptin—Oedema peripheral—Capecitabine—colon cancer	0.000481	0.00655	CcSEcCtD
Saxagliptin—Gastrointestinal disorder—Vincristine—colon cancer	0.000459	0.00626	CcSEcCtD
Saxagliptin—Fatigue—Vincristine—colon cancer	0.000459	0.00625	CcSEcCtD
Saxagliptin—Dyspepsia—Irinotecan—colon cancer	0.000456	0.00621	CcSEcCtD
Saxagliptin—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000452	0.00616	CcSEcCtD
Saxagliptin—Gastrointestinal disorder—Irinotecan—colon cancer	0.000447	0.00609	CcSEcCtD
Saxagliptin—Fatigue—Irinotecan—colon cancer	0.000447	0.00608	CcSEcCtD
Saxagliptin—Pancreatitis—Methotrexate—colon cancer	0.000445	0.00606	CcSEcCtD
Saxagliptin—Immune system disorder—Capecitabine—colon cancer	0.000441	0.006	CcSEcCtD
Saxagliptin—Dyspepsia—Fluorouracil—colon cancer	0.000437	0.00595	CcSEcCtD
Saxagliptin—Gastrointestinal pain—Vincristine—colon cancer	0.000435	0.00592	CcSEcCtD
Saxagliptin—Gastrointestinal disorder—Fluorouracil—colon cancer	0.000428	0.00583	CcSEcCtD
Saxagliptin—Malnutrition—Capecitabine—colon cancer	0.000425	0.00579	CcSEcCtD
Saxagliptin—Gastrointestinal pain—Irinotecan—colon cancer	0.000424	0.00577	CcSEcCtD
Saxagliptin—Upper respiratory tract infection—Methotrexate—colon cancer	0.000422	0.00575	CcSEcCtD
Saxagliptin—Abdominal pain—Vincristine—colon cancer	0.00042	0.00573	CcSEcCtD
Saxagliptin—Flatulence—Capecitabine—colon cancer	0.000419	0.0057	CcSEcCtD
Saxagliptin—Erectile dysfunction—Methotrexate—colon cancer	0.000418	0.00569	CcSEcCtD
Saxagliptin—Abdominal pain—Irinotecan—colon cancer	0.000409	0.00558	CcSEcCtD
Saxagliptin—Infestation—Methotrexate—colon cancer	0.000405	0.00551	CcSEcCtD
Saxagliptin—Infestation NOS—Methotrexate—colon cancer	0.000405	0.00551	CcSEcCtD
Saxagliptin—Urticaria—Fluorouracil—colon cancer	0.000394	0.00537	CcSEcCtD
Saxagliptin—Hypersensitivity—Vincristine—colon cancer	0.000392	0.00534	CcSEcCtD
Saxagliptin—Hypersensitivity—Irinotecan—colon cancer	0.000382	0.0052	CcSEcCtD
Saxagliptin—Asthenia—Vincristine—colon cancer	0.000382	0.0052	CcSEcCtD
Saxagliptin—Asthenia—Irinotecan—colon cancer	0.000372	0.00506	CcSEcCtD
Saxagliptin—Hypersensitivity—Fluorouracil—colon cancer	0.000366	0.00498	CcSEcCtD
Saxagliptin—Arthralgia—Capecitabine—colon cancer	0.000362	0.00493	CcSEcCtD
Saxagliptin—Myalgia—Capecitabine—colon cancer	0.000362	0.00493	CcSEcCtD
Saxagliptin—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.000359	0.00489	CcSEcCtD
Saxagliptin—Dizziness—Vincristine—colon cancer	0.000352	0.00479	CcSEcCtD
Saxagliptin—Pruritus—Fluorouracil—colon cancer	0.000351	0.00478	CcSEcCtD
Saxagliptin—Infection—Capecitabine—colon cancer	0.000344	0.00469	CcSEcCtD
Saxagliptin—Dizziness—Irinotecan—colon cancer	0.000343	0.00467	CcSEcCtD
Saxagliptin—Thrombocytopenia—Capecitabine—colon cancer	0.000339	0.00462	CcSEcCtD
Saxagliptin—Vomiting—Vincristine—colon cancer	0.000338	0.00461	CcSEcCtD
Saxagliptin—Skin disorder—Capecitabine—colon cancer	0.000337	0.00459	CcSEcCtD
Saxagliptin—Rash—Vincristine—colon cancer	0.000335	0.00457	CcSEcCtD
Saxagliptin—Dermatitis—Vincristine—colon cancer	0.000335	0.00456	CcSEcCtD
Saxagliptin—Headache—Vincristine—colon cancer	0.000333	0.00454	CcSEcCtD
Saxagliptin—Vomiting—Irinotecan—colon cancer	0.000329	0.00449	CcSEcCtD
Saxagliptin—Immune system disorder—Methotrexate—colon cancer	0.000328	0.00447	CcSEcCtD
Saxagliptin—Dizziness—Fluorouracil—colon cancer	0.000328	0.00447	CcSEcCtD
Saxagliptin—Rash—Irinotecan—colon cancer	0.000327	0.00445	CcSEcCtD
Saxagliptin—Dermatitis—Irinotecan—colon cancer	0.000326	0.00444	CcSEcCtD
Saxagliptin—Headache—Irinotecan—colon cancer	0.000324	0.00442	CcSEcCtD
Saxagliptin—Malnutrition—Methotrexate—colon cancer	0.000316	0.00431	CcSEcCtD
Saxagliptin—Nausea—Vincristine—colon cancer	0.000316	0.0043	CcSEcCtD
Saxagliptin—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000316	0.0043	CcSEcCtD
Saxagliptin—Vomiting—Fluorouracil—colon cancer	0.000315	0.0043	CcSEcCtD
Saxagliptin—Rash—Fluorouracil—colon cancer	0.000313	0.00426	CcSEcCtD
Saxagliptin—Dermatitis—Fluorouracil—colon cancer	0.000313	0.00426	CcSEcCtD
Saxagliptin—Headache—Fluorouracil—colon cancer	0.000311	0.00423	CcSEcCtD
Saxagliptin—Nausea—Irinotecan—colon cancer	0.000308	0.00419	CcSEcCtD
Saxagliptin—Dyspepsia—Capecitabine—colon cancer	0.000305	0.00416	CcSEcCtD
Saxagliptin—Gastrointestinal disorder—Capecitabine—colon cancer	0.000299	0.00408	CcSEcCtD
Saxagliptin—Fatigue—Capecitabine—colon cancer	0.000299	0.00407	CcSEcCtD
Saxagliptin—Nausea—Fluorouracil—colon cancer	0.000295	0.00401	CcSEcCtD
Saxagliptin—Gastrointestinal pain—Capecitabine—colon cancer	0.000283	0.00386	CcSEcCtD
Saxagliptin—Urticaria—Capecitabine—colon cancer	0.000275	0.00375	CcSEcCtD
Saxagliptin—Abdominal pain—Capecitabine—colon cancer	0.000274	0.00373	CcSEcCtD
Saxagliptin—Arthralgia—Methotrexate—colon cancer	0.000269	0.00367	CcSEcCtD
Saxagliptin—Myalgia—Methotrexate—colon cancer	0.000269	0.00367	CcSEcCtD
Saxagliptin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.000267	0.00364	CcSEcCtD
Saxagliptin—Anaphylactic shock—Methotrexate—colon cancer	0.000258	0.00352	CcSEcCtD
Saxagliptin—Infection—Methotrexate—colon cancer	0.000256	0.00349	CcSEcCtD
Saxagliptin—Hypersensitivity—Capecitabine—colon cancer	0.000255	0.00348	CcSEcCtD
Saxagliptin—Thrombocytopenia—Methotrexate—colon cancer	0.000253	0.00344	CcSEcCtD
Saxagliptin—Skin disorder—Methotrexate—colon cancer	0.000251	0.00341	CcSEcCtD
Saxagliptin—Asthenia—Capecitabine—colon cancer	0.000249	0.00339	CcSEcCtD
Saxagliptin—Pruritus—Capecitabine—colon cancer	0.000245	0.00334	CcSEcCtD
Saxagliptin—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000235	0.0032	CcSEcCtD
Saxagliptin—Dizziness—Capecitabine—colon cancer	0.000229	0.00312	CcSEcCtD
Saxagliptin—Dyspepsia—Methotrexate—colon cancer	0.000227	0.00309	CcSEcCtD
Saxagliptin—Gastrointestinal disorder—Methotrexate—colon cancer	0.000223	0.00304	CcSEcCtD
Saxagliptin—Fatigue—Methotrexate—colon cancer	0.000223	0.00303	CcSEcCtD
Saxagliptin—Vomiting—Capecitabine—colon cancer	0.00022	0.003	CcSEcCtD
Saxagliptin—Rash—Capecitabine—colon cancer	0.000219	0.00298	CcSEcCtD
Saxagliptin—Dermatitis—Capecitabine—colon cancer	0.000218	0.00297	CcSEcCtD
Saxagliptin—Headache—Capecitabine—colon cancer	0.000217	0.00296	CcSEcCtD
Saxagliptin—Gastrointestinal pain—Methotrexate—colon cancer	0.000211	0.00287	CcSEcCtD
Saxagliptin—Nausea—Capecitabine—colon cancer	0.000206	0.00281	CcSEcCtD
Saxagliptin—Urticaria—Methotrexate—colon cancer	0.000205	0.00279	CcSEcCtD
Saxagliptin—Abdominal pain—Methotrexate—colon cancer	0.000204	0.00278	CcSEcCtD
Saxagliptin—Hypersensitivity—Methotrexate—colon cancer	0.00019	0.00259	CcSEcCtD
Saxagliptin—Asthenia—Methotrexate—colon cancer	0.000185	0.00252	CcSEcCtD
Saxagliptin—Pruritus—Methotrexate—colon cancer	0.000183	0.00249	CcSEcCtD
Saxagliptin—Dizziness—Methotrexate—colon cancer	0.000171	0.00232	CcSEcCtD
Saxagliptin—Vomiting—Methotrexate—colon cancer	0.000164	0.00224	CcSEcCtD
Saxagliptin—Rash—Methotrexate—colon cancer	0.000163	0.00222	CcSEcCtD
Saxagliptin—Dermatitis—Methotrexate—colon cancer	0.000163	0.00221	CcSEcCtD
Saxagliptin—Headache—Methotrexate—colon cancer	0.000162	0.0022	CcSEcCtD
Saxagliptin—Nausea—Methotrexate—colon cancer	0.000153	0.00209	CcSEcCtD
